De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

RPG Life Sciences Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

RPG Life Sciences heeft een totaal eigen vermogen van ₹3.7B en een totale schuld van ₹0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk ₹5.1B en ₹1.4B. De EBIT RPG Life Sciences is ₹1.2B waardoor de rentedekking -131.3 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.3B.

Belangrijke informatie

Verhouding schuld/eigen vermogen

₹0

Schuld

Rente dekkingsratio	-131.3x
Contant	₹1.26b
Aandelen	₹3.75b
Totaal verplichtingen	₹1.38b
Totaal activa	₹5.13b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%

Jul 25

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

Aug 24

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jun 14

Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

Feb 09

Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

Jan 13

RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Dec 23

Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

Nov 11

Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Oct 21

Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

Sep 28

What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

Aug 31

With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

Aug 11

What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

Jul 28

Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Jul 10

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹3.0B ) RPGLIFE } overtreffen de korte termijn passiva ( ₹1.3B ).

Langlopende schulden: De kortetermijnactiva RPGLIFE ( ₹3.0B ) overtreffen de langetermijnschulden ( ₹70.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: RPGLIFE is schuldenvrij.

Schuld verminderen: RPGLIFE heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 22.7% was.

Schuldendekking: RPGLIFE heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: RPGLIFE heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

RPG Life Sciences Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Investor sentiment improves as stock rises 15%

Rpg Life Sciences Limited Announces Board Changes

Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%

RPG Life Sciences Limited Declares Equity Dividend for the Year Ended March 31, 2024

Investor sentiment improves as stock rises 17%

RPG Life Sciences Limited to Report Q1, 2025 Results on Jul 19, 2024

Full year 2024 earnings released: EPS: ₹53.00 (vs ₹40.90 in FY 2023)

Upcoming dividend of ₹16.00 per share

RPG Life Sciences Limited, Annual General Meeting, Jul 16, 2024

RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality

RPG Life Sciences Limited Recommends Equity Dividend for the Year Ended March 31, 2024

Full year 2024 earnings released: EPS: ₹53.01 (vs ₹40.90 in FY 2023)

RPG Life Sciences Limited to Report Q4, 2024 Results on Apr 30, 2024

Third quarter 2024 earnings released: EPS: ₹16.00 (vs ₹11.56 in 3Q 2023)

RPG Life Sciences Limited to Report Nine Months, 2024 Results on Feb 01, 2024

Second quarter 2024 earnings released: EPS: ₹15.64 (vs ₹12.08 in 2Q 2023)

Investor sentiment improves as stock rises 16%

RPG Life Sciences Limited to Report Q2, 2024 Results on Oct 18, 2023

RPG Life Sciences Limited Approves Dividend for the Financial Year Ended March 31, 2023

RPG Life Sciences Limited to Report Q1, 2024 Results on Jul 28, 2023

Full year 2023 earnings released: EPS: ₹40.90 (vs ₹31.13 in FY 2022)

Upcoming dividend of ₹12.00 per share at 1.2% yield

RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00

RPG Life Sciences Limited Recommends Payment of Final Dividend for the Financial Year 2022-23

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: ₹40.90 (vs ₹31.13 in FY 2022)

Third quarter 2023 earnings released: EPS: ₹11.56 (vs ₹8.85 in 3Q 2022)

RPG Life Sciences Limited to Report Q3, 2023 Results on Feb 01, 2023

Insufficient new directors

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹12.08 (vs ₹9.52 in 2Q 2022)

RPG Life Sciences Limited to Report Q2, 2023 Results on Oct 17, 2022

Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

RPG Life Sciences Limited Approves Dividend for the Financial Year Ended March 31, 2022

RPG Life Sciences Limited to Report Q1, 2023 Results on Aug 02, 2022

Full year 2022 earnings released: EPS: ₹31.13 (vs ₹24.19 in FY 2021)

Upcoming dividend of ₹9.60 per share

RPG Life Sciences Limited Proposes Final Dividend for the Financial Year Ended March 31, 2022

Now 20% undervalued

Now 21% undervalued

Now 21% undervalued after recent price drop

Full year 2022 earnings released: EPS: ₹31.13 (vs ₹24.19 in FY 2021)

RPG Life Sciences Limited to Report Q4, 2022 Results on Apr 29, 2022

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS ₹9.52 (vs ₹6.74 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

First quarter 2022 earnings released: EPS ₹8.21 (vs ₹5.48 in 1Q 2021)

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Full year 2021 earnings released: EPS ₹24.19 (vs ₹17.54 in FY 2020)

RPG Life Sciences Limited Recommends Equity Dividend for the Financial Year Ended March 31, 2021

Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?

New 90-day high: ₹406

RPG Life Sciences Limited to Report Q3, 2021 Results on Jan 25, 2021

Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?

RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?

Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?

First half earnings released

Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?

New 90-day high: ₹405

What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?

With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For

What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E

RPG Life Sciences Limited to Report Q1, 2021 Results on Jul 31, 2020

Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven